Li-Yao Huang
founderYC
Specializes inArtificial Intelligence
Founder at FinalDose (YC P26). DPhil in Biochemistry from Oxford, where he spent 5 years as a postdoctoral researcher at the MRC Weatherall Institute of Molecular Medicine. Led CRISPR screening projects uncovering new druggable targets in cancer cells and built pipelines reducing hit validation time from months to 7 days. Research focuses on BRCA1-deficient cancers and PARP inhibitor resistance mechanisms.
1
product
Products · 1
Worked alongside
Roles are derived from products, launches and repositories we track — not from self-description.